A share price of Centessa Pharmaceuticals plc ADR [CNTA] is currently trading at $17.84, up 3.48%. An important factor to consider is whether the stock is rising or falling in short-term value. The CNTA shares have gain 5.50% over the last week, with a monthly amount glided 6.57%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Previously, Morgan Stanley upgraded its rating to Overweight on September 20, 2024, and elevated its price target to $26. On September 19, 2024, B. Riley Securities initiated with a Buy rating and assigned a price target of $33 on the stock. Oppenheimer started tracking the stock assigning a Outperform rating and suggested a price target of $14 on July 18, 2024. Jefferies upgraded its rating to a Buy and raised its price target to $11 on November 15, 2023. Morgan Stanley upgraded its rating to Equal-Weight for this stock on October 26, 2023, and upped its price target to $8. In a note dated June 21, 2023, Evercore ISI initiated an Outperform rating.
Centessa Pharmaceuticals plc ADR experienced fluctuations in its stock price throughout the past year between $7.38 and $18.97. Currently, Wall Street analysts expect the stock to reach $23.25 within the next 12 months. Centessa Pharmaceuticals plc ADR [NASDAQ: CNTA] shares were valued at $17.84 at the most recent close of the market. An investor can expect a potential return of 30.33% based on the average CNTA price forecast.
Analyzing the CNTA fundamentals
Gross Profit Margin for this corporation currently stands at 0.9% with Operating Profit Margin at -23.43%, Pretax Profit Margin comes in at -22.95%, and Net Profit Margin reading is -23.37%. To continue investigating profitability, this company’s Return on Assets is posted at -0.26, Equity is -0.52 and Total Capital is -0.28. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.17.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 17.36 points at the first support level, and at 16.87 for the second support level. However, for the 1st resistance point, the stock is sitting at 18.24, and for the 2nd resistance point, it is at 18.63.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Centessa Pharmaceuticals plc ADR [NASDAQ:CNTA] is 21.52. On the other hand, the Quick Ratio is 21.52, and the Cash Ratio is 14.96. Considering the valuation of this stock, the price to sales ratio is 339.92, the price to book ratio is 4.71.
Transactions by insiders
Recent insider trading involved Anderson Karen M., Chief People Officer, that happened on Feb 03 ’25 when 6471.0 shares were sold. Chief Technology & Quality Ofc, Bush Tia L completed a deal on Feb 03 ’25 to sell 11000.0 shares. Meanwhile, Officer Bush Tia L bought 11000.0 shares on Feb 03 ’25.
